Equine anesthesia is associated with the development of numerous complications that may be implicated in this species’ high perioperative mortality rate.1,2 Hypoventilation, hypotension (mean arterial pressure [MAP] < 70 mmHg), and hypoxemia (PaO2 < 60 mmHg), occur relatively frequently during general anesthesia in horses, necessitating interventional treatment.3 These complications occur as a consequence of the administration of anesthetic drugs and the physical effects of recumbency.4–6
Mechanical ventilation (MV) is often used to counteract hypoventilation, but this may further aggravate the cardiovascular effects of general anesthesia.6–8
Hypotension (and poor cardiac output) is usually managed using infusions of dobutamine, a synthetic catecholamine with beta-1 agonistic activity.9 The improvement in cardiac contractility leads to increased cardiac output and blood pressure in healthy horses.4
Hypoxemia in anesthetized horses usually results from profound ventilation-perfusion (
Alternative solutions have been described that manipulate pulmonary perfusion rather than manage ventilation. The administration of pulsed inhaled nitric oxide (PiNO) to anesthetized horses, improves perfusion to ventilated lungs and reduces perfusion to atelectatic lung (reduced intrapulmonary shunting), and
This study aimed to document the effect of PiNO on pulmonary perfusion using CTA in mechanically ventilated, anesthetized ponies during periods of hypotension and normotension achieved using an infusion of dobutamine. We hypothesized that the delivery of PiNO during periods of hypotension would not redistribute pulmonary perfusion, compared with the delivery of PiNO during dobutamine administration.
Materials and Methods
This experiment was a prospective, experimental study. The local Ethical Committee on Animal Experiments in Uppsala, Sweden, approved this study, which included 6 healthy ponies (5 Shetland ponies and 1 crossbreed pony; 1 mare, 3 geldings, and 2 stallions) with a mean weight of 190 kg (150–241 kg) and a mean age 12 years (range = 4–18 years). Health status was confirmed on clinical examination and complete blood analysis.
Anesthesia
Ponies were anesthetized on 2 separate occasions using the same protocol. Food was withheld for 12 hours before general anesthesia and water was provided ad libitum until the point of venous catheterization. Premedication was with acepromazine (0.03 mg/kg−1) intramuscularly (IM) approximately 45 minutes before induction to general anesthesia. After subcutaneous infiltration with lidocaine, a catheter (14 G X 90 mm) was placed into the left jugular vein and two sheath introducers (8.5 Fr) into the right jugular vein. Further premedication was with xylazine (1.1 mg/kg−1) and butorphanol (0.025 mg/kg−1), administered intravenously (IV). General anesthesia was induced using ketamine (2.2 mg/kg−1) and diazepam (0.05 mg/kg−1), mixed in the same syringe, and given IV. Once unconsciousness was attained, the trachea was intubated with a size 20 mm endotracheal tube, and the pony hoisted onto an appropriately padded CT table with the head facing the CT gantry. The fore and hind limbs were allowed to fall into natural positions with padding inserted between the lower antebrachium and the metacarpal bone. The endotracheal tube was connected to a large animal anesthetic circuit and machine. Inserted between the breathing system and the endotracheal tube was an arrangement of pitot tubes for measurement of lung volumes and flow and a simple ball-valve tap to facilitate a breath-hold during CT acquisition. General anesthesia was maintained using isoflurane vaporized in oxygen with an inspired oxygen fraction (FIO2) of approximately 0.9. IV fluid therapy was administered throughout anesthesia using a balanced isotonic crystalloid solution, and ponies were mechanically ventilated throughout both anesthetics. Tidal volume and rate were adjusted to maintain PaCO2 between 45 and 68 mmHg and peak inspiratory pressure (PIP) was kept below 30 cmH2O. At the end of the experiment, anesthesia was terminated and the pony was hoisted into a padded stall and allowed to recover. Analgesia was provided at this time with flunixin meglumine (1.1 mg/kg−1) IV and morphine (0.1 mg/kg−1) IM.
Instrumentation and hemodynamic analysis
The facial artery was catheterized (18 G X 32 mm) for sampling arterial blood and measurement of systemic blood pressure. A thermodilution catheter (7F X 110 cm) was inserted into the pulmonary artery via one of the pre-placed introducers. This catheter was used for sampling of mixed venous blood and measurement of mean pulmonary arterial pressure (MPAP), pulmonary capillary wedge pressure (PCWP), and cardiac output (
A multiparameter monitor was connected to each pony to measure the ECG (Lead I), heart rate (HR), arterial hemoglobin oxygen saturation using pulse oximetry (SpO2), end-tidal (ET), and an inspired fraction (FI) of carbon dioxide (CO2), oxygen (O2) and anesthetic vapor, respiratory rate (fR), tidal volume (TV), PIP, systolic (SAP), MAP and diastolic (DAP) arterial blood pressures, MPAP, PCWP, and
Thermodilution was used to determine
Blood gas measurements
At each data collection point, arterial and mixed venous blood samples were simultaneously collected into heparinized syringes, from the facial arterial and the Swan-Ganz catheters, respectively, and analyzed immediately using a standard electrode technique (ABL 90 flex, Radiometer). Arterial pH (pHa), PaO2, PaCO2, arterial oxygen saturation (SaO2), hemoglobin concentration ([Hb]), mixed venous oxygen tension (P
Nitric oxide delivery
Delivery of PiNO during each anesthetic was achieved using an airway pressure-triggered device (Datex-Ohmeda Research Unit), which intermittently delivered a volumetric dose of NO from the beginning of inspiration for 30% to 45% of the total inspiratory time. The device was connected to a cylinder supply of 2000 ppm NO in N2 (AGA). The approximate dose of NO delivered during each breath was 2.5–5.0 μM.
Groups
During both anesthetics, hypotension (MAP between 44 and 52 mmHg) was allowed to develop over the initial 60 minutes of anesthesia while the ponies were being instrumented. For the following 60 minutes, PiNO was then delivered. In the first experiment (treatment group, n = 6), data were collected after 30 minutes of PiNO (time point T1). Dobutamine was then administered as a variable rate infusion (0.5 to 5.0 μg·kg−1·in−1) to maintain MAP between 70 and 80 mmHg for 30 minutes and data was collected again (time point T2). PiNO was then discontinued and dobutamine was discontinued in 3 ponies and was continued in 3 ponies. Data were collected after 45 minutes after PiNO cessation (time points T3a and T3b, respectively).
In the second experiment (control group, n = 5), hypotension (MAP 44 to 59 mmHg) was allowed to develop as described but was not treated and persisted throughout the entire anesthetic. Data were collected at 30 (time point C1) and 60 minutes (time point C2) of PiNO delivery. PiNO was discontinued and data was collected again after 30 minutes (time point C3).
CT data acquisition
A complete description of the CT angiography technique is reported elsewhere.13 In brief, dynamic axial scans were acquired at each time point using a third-generation, 64-slice multi-detector CT scanner (Somatom Definition AS, Siemens Medical Systems) at exposures of 70 mAs and 120 kV, slice thickness 15.0 mm and rotation time 0.33 seconds. Iodinated contrast agent (Omnipaque 300 mg/mL−1 GE Healthcare) was injected directly into the right atrium using the multi-hole pigtail catheter using an automated injector (Medrad Stellant dual syringe CT injection system, Bayer AG). CT scans were acquired with breath held at peak inspiration using the plumbing ball valve. Each scan sequence lasted 50 seconds. DICOM files as a series of 166 images at 3 per second were exported to Osirix (v.5.8.5 64-bit). CT images were analyzed using ImageJ (v1.49, National Institute of Health). Lung regions were delineated using threshold windows: for atelectatic lung 100 to −100 Hounsfield Units (HU); for poorly ventilated lung −100 to −500 HU; and for normally ventilated lung −500 to −1000 HU.23 Calculations of perfusion were made using the methodology described previously,13 and perfusion values are presented as milliliter blood minute−1 gram tissue−1.
Calculated data
Oxygen content of end capillary (Cc′O2), arterial (CaO2), and mixed venous (C
Alveolar oxygen tension (PAO2) was calculated using the alveolar gas equation: PAO2 = FIO2 (barometric pressure – water vapor pressure) - PACO2/RQ.24 Where: alveolar carbon dioxide tension (PACO2) is substituted with PaCO2 and respiratory quotient (RQ) is taken as 0.8. Oxygen delivery (DO2) was calculated as CaO2 X
The cardiac index (CI) was calculated as
Statistical analysis
Data for each pony were collected during 2 anesthetics: control (C) and treatment (T). During each anesthetic, data were collected at 3 time points, denoted 1, 2, and 3. Thus, there were 6 measurements per pony: C1, C2, and C3 and T1, T2, and T3 (a or b). Dobutamine was only given at measurement T2. Because there were several observations per pony, data were analyzed using the mixed procedure of the SAS/STAT software (SAS Institute Inc).26 The fixed part of the model included anesthetic (C or T), time, and the anesthetic*time interaction. The pony was set as a random factor. In a post hoc comparison, the average for measurements C1, C2, and T1 was compared with the T2 value; that is, the observation with active treatment was compared with the average of the untreated observations using linear contrasts. The assumptions were checked using diagnostic plots. No apparent deviations from normality or homoscedasticity were detected.
For time points after PiNO discontinuation (C3 and T3a or b), descriptive data are included. No statistical analysis was performed due to the small number of ponies included at these time points.
Results
Distribution of perfusion
In the control experiment, perfusion to all lung regions did not change over time during PiNO administration. In the treatment experiment, perfusion to well-ventilated lung regions (−500 to −1000 HU) increased significantly when dobutamine was administered. Perfusion to poorly ventilated lung regions (−100 to −500 HU), and atelectatic lung regions did not change significantly (Table 1).
Distribution of perfusion in different lung regions in mechanically ventilated anesthetized ponies during two different anesthetics.
Distribution of perfusion (mL blood/min/gram tissue) | ||||||
---|---|---|---|---|---|---|
T3a | ||||||
Lung region | C1 | C2 | C3 | T1 | T2* | T3b |
−500 to −1000 (HU) | 3.9 ± 1.2 | 3.7 ± 0.9 | 2.9 ± 0.4 | 4.1 ± 0.8 | 7.0 ± 3.3† | 3.6 ± 1.3 |
6.1 ± 0.4 | ||||||
−100 to −500 (HU) | 4.5 ± 1.1 | 4.4 ± 0.9 | 3.0 ± 0.4 | 4.3 ± 1.0 | 6.7 ± 2.1 | 3.3 ± 0.4 |
4.7 ± 0.5 | ||||||
100 to −100 (HU) | 3.8 ± 1.4 | 2.5 ± 0.9 | 2.0 ± 0.5 | 1.7 ± 1.4 | 2.7 ± 0.7 | 1.5 ± 0.3 |
2.7 ± 0.2 |
Control experiment time points: C1 = Hypotension and pulsed inhaled nitric oxide (PiNO) delivery for 30 min; C2 = Hypotension and PiNO delivery for 60 min; C3 = Hypotension and PiNO discontinued for 30 min. Treatment experiment time points: T1 = Hypotension and PiNO delivery for 30 min; T2 = Normotension (mean arterial pressure 70–80 mmHg achieved with dobutamine) and PiNO delivery for 60 min; T3a = Hypotension and PiNO discontinued for 45 min; T3b = Normotension (continued dobutamine administration) and PiNO discontinued for 45 min.
A significant interaction was seen between the distribution of perfusion to lung regions and the effect of dobutamine during concurrent pulsed inhaled nitric oxide,
P < .001. Difference in perfusion compared with the previous measurement,
P < .021. Time points T3a and T3b were not tested statistically.
During the treatment experiment, the 6 ponies were divided into 2 further subgroups once PiNO was discontinued. In the first subgroup in which hypotension developed again, perfusion to the atelectatic lung (100 to −100 HU) decreased. In the second subgroup in which normotension was maintained, perfusion to the atelectatic lung did not change. These results were not tested statistically due to the small number of ponies within each subgroup.
Physiological data
In the control group (Table 2), there were no significant differences in any physiological parameters or any of the calculated data recorded over the entire experimental period.
Physiological parameters during control experiment in mechanically ventilated anesthetized ponies.
Anaesthesia 1 – Control group | |||
---|---|---|---|
Variable | C1 n = 5 | C2 n = 5 | C3 n = 5 |
MAP (mmHg) | 56 ± 6 | 54 ± 3 | 54 ± 1 |
MPAP (mmHg) | 15.6 ± 3.5 | 15.6 ± 2.5 | 14.7 ± 1.5 |
10.5 ± 3.3 | 8.9 ± 0.7 | 8.2 ± 0.9 | |
HR (beats/min) | 42 ± 6 | 40 ± 4 | 39 ± 2.1 |
VE (L/min) | 20.3 ± 1.6 | 20.3 ± 4.1 | 19.8 ± 2.0 |
PaCO2 (kPa) | 6.8 ± 1.3 | 6.9 ± 1.5 | 7.5 ± 1.8 |
Vd/Vt (%) | 19 ± 3 | 22 ± 4 | 25 ± 6 |
28 ± 4 | 28 ± 4 | 37 ± 5 | |
P(A-a)O2 (kPa) | 37.1 ± 5.9 | 39.1 ± 8.8 | 46.0 ± 14.5 |
PaO2 (kPa) | 39.2 ± 10.1 | 38.3 ± 10.1 | 35.8 ± 16.9 |
SaO2 (%) | 96.5 ± 0.4 | 96.5 ± 0.4 | 96.1 ± 1.0 |
DO2 (L/min) | 1.09 ± 0.28 | 0.96 ± 0.20 | 0.85 ± 0.20 |
[Hb] (g/L) | 74.0 ± 14.1 | 75.0 ± 16.7 | 73.0 ± 14.1 |
ETiso (%) | 1.5 ± 0.2 | 1.8 ± 0.2 | 1.6 ± 0.2 |
See Table 1 for group descriptions. DO2 = Oxygen delivery; ETiso = End-tidal isoflurane concentration; [Hb] = Hemoglobin concentration; HR = Heart rate; MAP = Mean arterial blood pressure; MPAP = Mean pulmonary arterial pressure; P(A-a)O2 = Alveolar-arterial oxygen tension difference; PaCO2 = Arterial partial pressure of carbon dioxide; PaO2 = Arterial partial pressure of oxygen;
In the treatment group (Table 3), there was a significant interaction when delivering PiNO and administering dobutamine: MAP, MPAP,
Physiological parameters during treatment experiment in mechanically ventilated anesthetized ponies.
Anaesthesia 2 – Treatment group | |||
---|---|---|---|
T3a n = 3 | |||
Variable | T1 n = 6 | T2 n = 6 | T3b n = 3 |
MAP* (mmHg) | 54 ± 2 | 76 ± 2 | 46.7 ± 1.5 |
72.7 ± 1.5 | |||
MPAP* (mmHg) | 8.2 ± 2.8 | 13.7 ± 3.9† | 9.3 ± 4.2 |
18.7 ± 0.6 | |||
9.1 ± 2.2 | 17.2 ± 4.5† | 7.7 ± 0.8 | |
20.4 ± 0.6 | |||
HR * (beats/min) | 41 ± 4 | 53 ± 9 † | 39 ± 6 |
68 ± 15 | |||
VE (L/min) | 19.0 ± 4.3 | 19.1 ± 4.1 | 16.4 ± 2.2 |
22.1 ± 3.9 | |||
PaCO2 (kPa) | 6.9 ± 1.1 | 7.4 ± 1.0 | 6.3 ± 1.4 |
8.3 ± 0.6 | |||
VD/VT * (%) | 27 ± 4 | 25 ± 2 | 27 ± 1 |
33 ± 3 | |||
26 ± 7 | 33 ± 6‡ | 25 ± 9 | |
43 ± 4 | |||
P(A-a)O2 * (kPa) | 37.3 ± 9.6 | 22.8 ± 5.5‡ | 30.8 ± 19.2 |
34.0 ± 9.7 | |||
PaO2 * (kPa) | 37.8 ± 10.1 | 51.8 ± 5.5† | 46.4 ± 21.6 |
40.2 ± 0.8 | |||
SaO2 (%) | 96.7 ± 0.3 | 96.8 ± 0.2 | 96.7 ± 0.3 |
96.6 ± 0.0 | |||
DO2 * (L/min) | 0.93 ± 0.21 | 2.8 ± 0.9‡ | 0.91 ± 0.17 |
3.2 ± 0.17 | |||
[Hb]* (g/L) | 81.3 ± 8.4 | 114.5 ± 8.4‡ | 81.0 ± 5.3 |
112.3 ± 7.2 | |||
ETiso (%) | 1.3 ± 0.3 | 1.3 ± 0.1 | 1.3 ± 0.3 |
1.2 ± 0.1 |
During the treatment experiment, the 6 ponies were divided into 2 further subgroups once PiNO was discontinued. In the second subgroup in which dobutamine administration continued and normotension was maintained,
Discussion
Using CTA, we have demonstrated that when blood pressure and
Mechanical ventilation can affect oxygenation in several ways. Global
The administration of PiNO has been shown to reduce PVR in anesthetized ponies but this is of little clinical significance.15 However, PiNO may offset the increase in PVR that is observed with MV as described above and minimize the negative effects on
The relatively wide range of PaCO2 values observed in this study may have affected PVR. However, the independent effects of CO2 on the equine pulmonary vasculature have not been described, and there are contradictory reports on other species. In hypoxaemic dogs, PVR was elevated in the presence of increased CO2,32 whilst in isolated rat lungs, PVR decreased in response to hypercapnia.33 In previous studies, we have compared spontaneously breathing ponies with those that were mechanically ventilated. In those experiments, PaCO2 was lower in the MV group but no differences in PVR were observed regardless of ventilation mode, suggesting that PaCO2 had little influence on the overall results.14
In this study, hypotension and poor
In the past, it has been demonstrated that dobutamine improves
There were some limitations to this study. Due to the size of the CT gantry, this study was limited to ponies up to a certain size. Although pulmonary physiology is similar between horses and ponies, the magnitude of gas exchange derangements is known to be associated with body mass and dimensions of the thorax.50 This may be a reason why none of the ponies studied developed significant hypoxemia during anesthesia (PaO2 < 60 mmHg). However, this study aimed to document the effect of PiNO on regional pulmonary perfusion during periods of hypotension and mechanical ventilation and to compare this during treatment with dobutamine. We were able to show that there was a significant effect on pulmonary perfusion and oxygenation indices when
When anesthetized ponies are hypotensive and mechanically ventilated, the effect of PiNO on regional pulmonary perfusion and
References
- 1.↑
Johnston GM, Eastment JK, Wood JLN, Taylor PM. The confidential enquiry into perioperative equine fatalities (CEPEF): mortality results of Phases 1 and 2. Vet Anaesth Analg. 2002;29:159–170. doi:10.1046/j.1467-2995.2002.00106.x
- 2.↑
Dugdale AHA, Obhrai J, Cripps PJ. Twenty years later: a single-centre, repeat retrospective analysis of equine perioperative mortality and investigation of recovery quality. Vet Anaesth Analg. 2016;43:171–178. doi:10.1111/vaa.12285
- 3.↑
Auckburally A & Nyman G. Review of hypoxaemia in anaesthetized horses: predisposing factors, consequences and management. Vet Anaesth Analg. 2017;44:397–408. doi:10.1016/j.vaa.2016.06.001
- 4.↑
Swanson CR, Muir WW, Bednarski RM, Skarda RT, Hubbell JA. Hemodynamic responses in halothane-anesthetized horses given infusions of dopamine or dobutamine. Am J Vet Res. 1985;46(2):365–370.
- 5.↑
Nyman G, Hedenstierna G. Ventilation-perfusion relationships in the anaesthetised horse. Equine Vet J. 1989;21(4):274–281. doi:10.1111/j.2042-3306.1989.tb02167.x
- 6.↑
Edner A, Nyman G, Essen-Gustavsson B. The effects of spontaneous and mechanical ventilation on central cardiovascular function and peripheral perfusion during isoflurane anaesthesia in horses. Vet Anaesth Analg. 2005;32:136–146. doi:10.1111/j.1467-2995.2005.00190.x
- 7.↑
Cournand A, Motley HL, Werko L, Richards DW. Physiologic studies on the effects of intermittent positive pressure breathing on cardiac output in man. Am J Physiol. 1948;52:162–174.
- 8.↑
Raisis AL, Blissitt KJ, Henley W, Rogers K, Adams V, Young LE. The effects of halothane and isoflurane on cardiovascular function in laterally recumbent horses. Br J Anaesth. 1995;95(3):317–325. doi:10.1093/bja/aei180
- 9.↑
Schauvliege S, Gasthuys F. Drugs for cardiovascular support in anesthetized horses. Vet Clin North Am Equine Pract. 2013;29(1):19–49. doi:10.1016/j.cveq.2012.11.011
- 10.↑
West JB, Dollery CT, Naimark A. Distribution of blood flow in isolated lung: relation to vascular and alveolar pressures. J Appl Physiol. 1964;19:713–724. doi:10.1152/appl.1964.19.4.713
- 11.↑
Swanson CR, Muir WW. Hemodynamic and respiratory responses in halothane-anesthetized horses exposed to positive end-expiratory pressure alone and with dobutamine. Am J Vet Res. 1988;49(4):539–542.
- 12.↑
Grubb TL, Lord PF, Berger M, et al. Effects of pulse-delivered inhaled nitric oxide administration on pulmonary perfusion and arterial oxygenation in dorsally recumbent isoflurane-anesthetized horses. Am J Vet Res. 2014;75(11):949–955. doi:10.2460/ajvr.75.11.949
- 13.↑
Auckburally A, Nyman G, Wiklund M, et al. Development of a method to measure regional perfusion of the lung in anesthetized ponies using computed tomography angiography and the maximum slope model. Am J Vet Res. 2022;83(2):162–170. doi:10.2460/ajvr.21.03.0035
- 14.↑
Auckburally A, Wiklund M, Lord P, Hedenstierna G, Nyman G. Effects of pulsed inhaled nitric oxide delivery on the distribution of pulmonary perfusion in spontaneously breathing and mechanically ventilated anesthetized ponies. Am J Vet Res. 2022;83(2):171–179. doi:10.2460/ajvr.21.03.0036
- 15.↑
Heinonen E, Hedenstierna G, Meriläinen P, Högman M, Nyman G. Pulsed delivery of nitric oxide counteracts hypoxaemia in the anaesthetised horse. Vet Anaesth Analg. 2001;28:3–11. doi:10.1046/j.1467-2987-2000.00035.x
- 16.
Heinonen E, Nyman G, Meriläinen P, Högman M. Effect of different pulses of nitric oxide on venous admixture in the anaesthetized horse. Br J Anaesth. 2002;88(3):394–398. doi:10.1093/bja/88.3.394
- 17.
Grubb TL, Högman M, Edner A, et al. Physiologic responses and plasma endothelin-1 concentrations associated with abrupt cessation of nitric oxide inhalation in isoflurane-anesthetized horses. Am J Vet Res. 2008;69(3):423–430. doi:10.2460/ajvr.69.3.423
- 18.
Nyman G, Grubb TL, Heinonen E, et al. Pulsed delivery of inhaled nitric oxide counteracts hypoxaemia during 2.5 hours of inhalation anaesthesia in dorsally recumbent horses. Vet Anaesth Analg. 2012;39:480–487. doi:10.1111/j.1467-2995.2012.00740.x
- 19.↑
Wiklund M, Granswed I, Nyman G. Pulsed inhaled nitric oxide improves arterial oxygenation in colic horses undergoing abdominal surgery. Vet Anaesth Analg. 2017;44(5):1139–1148. doi:10.1016/j.vaa.2016.11.015
- 20.↑
Auckburally A, Grubb TL, Wiklund M, Nyman G. Effects of ventilation mode and blood flow on arterial oxygenation during pulse-delivered inhaled nitric oxide in anesthetized horses. Am J Vet Res. 2019;80:275–283. doi:10.2460/ajvr.80.2.275
- 21.↑
Vizza CD, Della Rocca G, Di Roma A, et al. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care. 2001;5:355–361. doi:10.1186/cc1069
- 23.↑
Vieira SRR, Puybasset L, Richecoeur J, et al. A lung computed tomographic assessment of positive end-expiratory pressure-induced lung overdistension. Am J Respir Crit Care Med. 1998;158:1571–1577. doi:10.1164/ajrccm.161.4.16147b
- 24.↑
West JB. Respiratory Physiology: The Essentials. 8th ed. Lippincott Williams and Wilkins. 2008.
- 25.↑
Berggren SM. Oxygen deficit of arterial blood by non ventilating parts of the lung. Acta Physiol Scand. 1942;4(Suppl II):7–92.
- 26.↑
Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O. SAS for Mixed Models. 2nd ed. SAS Institute Inc. 2006.
- 27.↑
Day TK, Gaynor JS, Muir WW, Bednarski RM, Mason DE. Blood gas values during intermittent positive pressure ventilation and spontaneous ventilation in 160 anesthetized horses positioned in lateral or dorsal recumbency. Vet Surg. 1995;24:266–276. doi:10.1111/j.1532-950X.1995.tb01330.x
- 28.↑
Tyberg JV, Grant DA, Kingma I, et al. Effects of positive intrathoracic pressure on pulmonary and systemic hemodynamics. Respir Physiol. 2000;119:163–171. doi:10.1016/s0034-5687(99)00112-7
- 29.↑
Cairo JM. Effects of positive-pressure ventilation on the pulmonary system. In: Pilbeam SP, ed. Pilbeam’s Mechanical Ventilation – Physiological Concepts and Clinical Applications. 5th ed. Elsevier; 2012:327–352.
- 30.↑
Tyler DC. Positive end-expiratory pressure: a review. Crit Care Med. 1983;11(4):300–308. doi:10.1097/00003246-198304000-00012
- 31.↑
Bradford KK, Bhaskar D, Pearl RG. Combination therapy with inhaled nitric oxide and intravenous dobutamine during pulmonary hypertension in the rabbit. J Cardiovasc Pharm. 2000;36(2):146–151. doi:10.1097/00005344-200008000-00002
- 32.↑
Malik AB, Kidd BS. Independent effects of changes in H+ and CO2 concentrations on hypoxic pulmonary vasoconstriction. J Appl Physiol. 1973;34:318–323. doi:10.1152/jappl.1973.34.3.318
- 33.↑
Chuang IC, Dong HP, Yang RC, Wang TH, Tsai JH, Yang PH, Huang MS. Effect of carbon dioxide on pulmonary vascular tone at various pulmonary arterial pressure levels induced by endothelin-1. Lung. 2010;188:199–207. doi:10.1007/s00408-010-9234-7
- 34.↑
Wildsmith JAW, Drummond GB, MacRae WR. Blood-gas changes during induced hypotension with sodium nitroprusside. Br J Anaesth. 1975;47:1205–1211. doi:10.1093/bja/47.11.1205
- 35.↑
Casthely PA, Lear S, Cottrell JE, Lear E. Intrapulmonary shunting during induced hypotension. Anesth Analg. 1982;61:231–235. PMID:6802027.
- 36.↑
Nicholas JF, Lam AM. Isoflurane-induced hypotension does not cause impairment in pulmonary gas exchange. Can Anaesth Soc J. 1984;31;352–358. doi:10.1007/bf03015401
- 37.↑
Mizuno Y, Aida H, Fujinaga T. Effects of dobutamine infusion in dorsally recumbent isoflurane-anesthetized horses. J Eq Sci. 1994;5(3):87–94. doi:10.1294/jes.5.87
- 38.↑
Young LE, Blissitt KJ, Clutton RE, Molony V. Temporal effects of an infusion of dobutamine hydrochloride in horses anesthetized with halothane. Am J Vet Res. 1998;59(8):1027–1032.
- 39.↑
Swanson CR, Muir WW. Dobutamine-induced augmentation of cardiac output does not enhance respiratory gas exchange in anesthetized recumbent healthy horses. Am J Vet Res. 1986;47(7):1573–1576.
- 40.↑
Molloy DW, Ducas J, Dobson K, Girling L, Prewitt RM. Hemodynamic management in clinical acute hypoxemic respiratory failure. Dopamine vs dobutamine. Chest. 1986;89:636–640. doi:10.1378/chest.89.5.636
- 41.↑
Rennotte MT, Reynaert M, Clerbaux T, et al. Effects of two inotropic drugs, dopamine and dobutamine, on pulmonary gas exchange in artificially ventilated patients. Int Care Med. 1989;15:160–165. doi:10.1007/bf1058567
- 42.↑
Russell WJ, James MF. The effects on arterial haemoglobin saturation and on shunt of increasing cardiac output with dopamine or dobutamine during one-lung ventilation. Anaesth Int Care. 2004;32:644–648. doi:10.1177/031005X0403200506
- 43.↑
Smith G, Cheney FW, Winter PM. The effect of change in cardiac output on intrapulmonary shunting. Br J Anaesth. 1974;46:337–342. doi:10.1093/bja/46.5.337
- 44.↑
Lynch JP, Mhyre JG, Dantzker DR. Influence of cardiac output on intrapulmonary shunt. J Appl Physiol. 1979;46:315–321. doi:10.1152/jappl.1979.46.2.315
- 45.↑
Stickland MK, Lovering AT. Exercise-induced intrapulmonary arteriovenous shunting and pulmonary gas exchange. Exercise Sport Sci Rev. 2006;34:99–106. doi:10.1249/00003677-200607000-00003
- 46.↑
Stickland MK, Lovering AT, Eldridge MW. Exercise-induced arteriovenous intrapulmonary shunting in dogs. Am J Respir Crit Care Med. 2007;176:300–305. doi:10.1164/rccm.200702-206OC
- 47.↑
Prinzmetal M, Ornitz EM, Simkin B, Bergman HC. Arterio-venous anastomoses in liver, spleen and lungs. Am J Physiol. 1948;152:48–52. doi:10.1152/ajplegacy.1947.152.1.48
- 48.↑
Manohar M, Goetz TE. Intrapulmonary arteriovenous shunts of > 15μm in diameter probably do not contribute to arterial hypoxaemia in maximally exercising Thoroughbred horses. J Appl Physiol. 2005;99:224–229. doi:10.1152/japplphysiol.01230.2004
- 49.↑
La Gerche A, Daffy JR, Mooney DJ, Forbes G, Davie AJ. Transit of micro-bubbles through the pulmonary circulation of Thoroughbred horses during exercise. Res Vet Sci. 2013;95;644–647. doi:10.1016/j.rvsc.2013.04.002
- 50.↑
Mansell JC, Clutton RE. The influence of body mass and thoracic dimensions on arterial oxygenation in anaesthetized horses and ponies. Vet Anaesth Analg. 2008;35:392–399. doi:10.1111/j.1467-2995.2008.00400.x